1- Ginsberg JA, Crowther MA, White RH, Ortel TL. Anticoagulation therapy. Hematology Am Soc Hematol Educ Program 2001:339–357
2- Segal JB, McNamara RL, Miller MR, Kim N, Goodman SB, Powe NR, et al. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 15 (2000) 56–67
3- Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 28 (2000) 419–422.
4- Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110 (2003) 1784–1788.
5- Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 31 (2011) 1983–1987.
6- Chandra A, Jazayeri F, Williamson TH. Warfarin in vitreoretinal surgery: a case controlled series. Br J Ophthalmol 95 (2011) 976- 978.
7- Fu AD, McDonald R, Williams DF, Cantrill HL, Ryan EH, Johnson RN. Anticoagulation with warfarin in vitreoretinal surgery. Retina 27 (2007) 290–295.
8- Mason JO, Gupta SR, Compton CJ, Frederick BS, Neimkin MG, Hill ML, et al. Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology 118 (2011) 543–547.
9- Dayani PN, Grand G. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc 104 (2006) 149-160.
10- Grand MG, Walia HS. Hemorrhagic risk of vitreoretinal surgery in patients mantained on novel anticoagulant therapy. Retina 36 (2016) 299-304.
11- Meillon C, Gabrielle PH, Luu M, Aho-Glele LS, Bron AM, Creuzot-Garcher C. Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol. Epub ahead of print.
12- Douketis J. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 108 (2002) 3-13.
13- Hewitt RL, Chun KL, Flint LM. Current clinical concepts in perioperative anticoagulation. Am Surg 65 (1999) 270–273.
14- Kearon C. Perioperative management of long-term anticoagulation. Semin Thromb Hemost 24 (1998) 77–83.
15- Stone LS, Kline OR, Sklar C. Intraocular lenses and anticoagulation and antiplatelet therapy. Am Intraocular Implant Soc J 11 (1985) 165–168.
16- Bullingham A, Priestly M. Anaesthetic management of patients being treated with anticoagulants: anesthesia and medical disease. Curr Opin Anaethesiol 10 (1997) 234–239.
17- Palareti G, Legnani C, Guazzaloca G, Abate A, Di Nucci GD, Iacopino G. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants. A prospective study. Thromb Haemost 71 (1994) 222– 226.
18- Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 92 (1996) 479–85.
19- Grip L, Blomback M, Schulman S. Hypercoagulable state and thromboembolism following warfarin withdrawal in postmyocardial-infarction patients. Eur Heart J 12 (1991) 1225–33.
20- Oh J, Smiddy WE, Kim SS. Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 151 (2011) 934-939.
21- Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 81 (2003) 38–40.
22- Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Eng J Med 368 (2013) 2113-2124.
23- Bonhomme F, Hafezi F, Boehlen F, Habre W. Management of antithrombotic therapies in patients scheduled for eye surgery. Eur J Anaesthesiol 30 (2013) 449-454.
24- McClellan AJ, Flynn HW Jr, Smiddy WE, Gayer SI. The use of perioperative antithrombotics in posterior segment ocular surgery. Am J Ophthalmol 158 (2014) 858-859.
25- McClellan AJ, Flynn HW Jr, Gayer S. A novel issue for vitreoretinal surgeons. Retina 36 (2016) 245-246.